In addition, these factors also stimulate inflammation-related damage to the nervous system, contributing to ...

The drug candidate was demonstrated to be well-tolerated and the pain and quality of life survey results suggested a potential for rapid improvement of peripheral neuropathy symptoms and post ...

Out-of-pocket costs continue to increase for patients who must buy commonly prescribed drugs to treat these five neurological ...

Neuropathy affects nearly 25 million Americans every day and the typical solution only masks the problem without getting to the root cause. Health From Within Chiropractic has a better ...

MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) stock is trading higher on Monday after the company released new preclinical ...

The amount of money people pay out-of-pocket for branded drugs to treat neurological diseases like multiple sclerosis (MS), ...

Generic medications reduce the out-of-pocket (OOP) costs for common neurological conditions, apart from multiple sclerosis, ...

Alkem Laboratories partners with Sonnet BioTherapeutics to develop and commercialize SON-080, a potential treatment for diabetic peripheral neuropathy in India. The drug has shown promising nerve ...

The drug was well-tolerated, and the trial results suggested potential for rapid improvement in peripheral neuropathy symptoms and long-lasting effects compared to a placebo. Akhilesh Sharma ...

While a confirmed cure for neuropathy does not currently exist, numerous methods are accessible to control its symptoms. These include prescription drugs, physical therapy, and nutritional ...